A detailed history of Tortoise Investment Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 2,135 shares of AXSM stock, worth $170,906. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,135
Previous 2,135 -0.0%
Holding current value
$170,906
Previous $171,000 11.7%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$36.06 - $69.85 $29,749 - $57,626
825 Added 62.98%
2,135 $95,000
Q4 2021

Feb 10, 2022

BUY
$30.7 - $43.36 $40,217 - $56,801
1,310 New
1,310 $49,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.43B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Tortoise Investment Management, LLC Portfolio

Follow Tortoise Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.